Biobase Blood Coagulation Analyzer Bk-Ca02 Bk-Ca04 for Hospital

Name: Biobase Blood Coagulation Analyzer Bk-Ca02 Bk-Ca04 for Hospital
Brand: Biobase Biolin Co., Ltd.
SKU: 1927905701

Shandong, ChinaBiobase Biolin Co., Ltd.

US$500.00-1,500.00

1 Piece

Sample price:US$3000.00/piece.Request sample

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Blood Coagulation Analyzer

Model NO.

BK-CA02

Certification

CE, FDA

Group

All

Test Principle

Optical Colorimetry

Wavelength

470nm

Sample Incubation Position

Reagent Incubation Position

Detection Position Temperature

37.0±1.0°C

Incubation Position Temperature

37.0±1.0°C

Incubation Time

1~999s

Reaction Time

1~99s

Reagent Dosage

Minimum Dosage 20μL

Sample Volume

20μL~40μL

Display

5-Inch High-Definition Color Touch Screen

Storage

20,000 Results Storage, Automatically Save Measure

Communication Interface

RS232 Serial Interface, Support Lis System

Printer

Built-in Thermal Printer

Power Supply

AC100~240V, 50/60Hz

Transport Package

Wooden

Specification

728*530*884mm

Trademark

BIOBASE

Origin

China

HS Code

9027899090

Production Capacity

10000unit/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceMulti-language PioneerExperienced Team

Biobase Biolin Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8.5 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.83h

AI-Powered supplier vetting

SummaryThe supplier is identified as a limited trading company in Jinan, offering laboratory equipment, medical devices, biochemistry analyzers, autoclaves, biological safety cabinets, and related products. It reports ODM, OEM, professional technical, 3D design, and flexible customization capabilities, along with overseas service offerings and a stated export-sales share of 90%. Service procedures are mixed: complaint handling and corrective/preventive action procedures have records, while effective service-capability assessment procedures lack written procedures and records. No overseas showroom, agent, branch, offline trade-show participation, SDK, or new-product launch is reported. Production quantities are stated for three products, but the supplier’s manufacturing status is unclear because it is classified as a trading company.

Supplier typeThe supplier is explicitly classified as a Trading Company and Limited Company, with a business scope centered on sales of medical equipment, office supplies, software, electronic products, and related items. It is not identified as part of a larger company group, and its associated industry is wholesale and retail.

After-Sales capabilityThe supplier reports overseas training, equipment installation, repair, maintenance, and debugging services, with 10 qualified service suppliers and stated lead times of within 15 working days off-season and one month during peak season. Complaint handling and corrective/preventive-action procedures have records, but the assessment procedure for effective service capability lacks written procedures and records; there are also no overseas showrooms, agents, branches, or offline trade-show experience.

R&D capabilityThe supplier reports ODM service, professional technical R&D capability, 3D software design, and flexible customization. However, it reports no new products launched in the past year and no available SDK, while product-information R&D capability is also marked as absent.

Customization capabilityThe supplier explicitly provides ODM services, 3D software design services, and flexible customization through its design and R&D capabilities. These statements directly support the availability of customized design or product solutions.